Marshall Urist
EVP, Research & Investments · 12 filings · Latest: Oct 5, 2026
Royalty Pharma plc
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
RPRX | Marshall Urist | EVP, Research & Investments | Oct 5, 2026 | Sale | $57.10 | 4,126 | $235.6K | 0 | |
RPRX | Urist Marshall | — | Oct 5, 2026 | Proposed Sale | $57.10 | 4,126 | $235.6K | — | |
RPRX | Marshall Urist | EVP, Research & Investments | Sep 28, 2026 | Sale | $57.88 | 4,126 | $238.8K | 4,126 | |
RPRX | Urist Marshall | — | Sep 28, 2026 | Proposed Sale | $57.88 | 4,126 | $238.8K | — | |
RPRX | Marshall Urist | EVP, Research & Investments | Jul 1, 2026 | Sale | $55.88 | 9,099 | $508.5K | 0 | |
RPRX | Urist Marshall | — | Jul 1, 2026 | Proposed Sale | $55.88 | 9,099 | $508.5K | — | |
RPRX | Marshall Urist | EVP, Research & Investments | Jun 24, 2026 | Sale | $55.18 | 9,098 | $502.1K | 9,099 | |
RPRX | Urist Marshall | — | Jun 24, 2026 | Proposed Sale | $55.18 | 9,098 | $502.1K | — | |
RPRX | Marshall Urist | EVP, Research & Investments | May 20, 2026 | Sale | $52.75 | 13,684 | $721.8K | 18,197 | |
RPRX | Urist Marshall | — | May 20, 2026 | Proposed Sale | $52.75 | 13,684 | $721.8K | — | |
RPRX | Marshall Urist | EVP, Research & Investments | May 14, 2026 | Sale | $53.06 | 13,684 | $726.1K | 31,881 | |
RPRX | Urist Marshall | — | May 14, 2026 | Proposed Sale | $53.06 | 13,684 | $726.1K | — | |
RPRX | Marshall Urist | EVP, Research & Investments | Jan 30, 2026 | Sale | $41.09 | 20,000 | $821.8K | 0 | |
RPRX | Marshall Urist | EVP, Research & Investments | Jan 23, 2026 | Sale | $40.26 | 20,000 | $805.1K | 20,000 | |
RPRX | Marshall Urist | EVP, Research & Investments | Jan 16, 2026 | Sale | $39.52 | 20,000 | $790.3K | 40,000 | |
RPRX | Urist Marshall | — | Dec 1, 2025 | Proposed Sale | $39.90 | 36,484 | $1.5M | — |